Volume 15, Issue 11
Research Article

ON DESIGN CONSIDERATIONS AND RANDOMIZATION‐BASED INFERENCE FOR COMMUNITY INTERVENTION TRIALS

MITCHELL H. GAIL

Corresponding Author

National Cancer Institute, Division of Cancer Etiology, Executive Plaza North, Room 431, 6130 Executive Blvd., MSC 7368, Bethesda, MD 20892‐7368, U.S.A.

National Cancer Institute, Division of Cancer Etiology, Executive Plaza North, Room 431, 6130 Executive Blvd., MSC 7368, Bethesda, MD 20892‐7368, U.S.A.Search for more papers by this author
STEVEN D. MARK

National Cancer Institute, Division of Cancer Etiology, Executive Plaza North, Room 431, 6130 Executive Blvd., MSC 7368, Bethesda, MD 20892‐7368, U.S.A.

Search for more papers by this author
RAYMOND J. CARROLL

Department of Statistics, Texas A&M University, College Station, TX 77843‐3143, U.S.A. and Guest Researcher, National Cancer Institute, Bethesda, U.S.A.

Search for more papers by this author
SYLVAN B. GREEN

National Cancer Institute, Division of Cancer Prevention and Control, Executive Plaza North, Room 344, 6130 Executive Blvd., MSC 7354, Bethesda, MD 20892‐7354, U.S.A.

Search for more papers by this author
DAVID PEE

Information Management Services, 6110 Executive Blvd., Rockville, MD 20852, U.S.A.

Search for more papers by this author

Abstract

This paper discusses design considerations and the role of randomization‐based inference in randomized community intervention trials. We stress that longitudinal follow‐up of cohorts within communities often yields useful information on the effects of intervention on individuals, whereas cross‐sectional surveys can usefully assess the impact of intervention on group indices of health. We also discuss briefly special design considerations, such as sampling cohorts from targeted subpopulations (for example, heavy smokers), matching the communities, calculating sample size, and other practical issues. We present randomization tests for matched and unmatched cohort designs. As is well known, these tests necessarily have proper size under the strong null hypothesis that treatment has no effect on any community response. It is less well known, however, that the size of randomization tests can exceed nominal levels under the ‘weak’ null hypothesis that intervention does not affect the average community response. Because this weak null hypothesis is of interest in community intervention trials, we study the size of randomization tests by simulation under conditions in which the weak null hypothesis holds but the strong null hypothesis does not. In unmatched studies, size may exceed nominal levels under the weak null hypothesis if there are more intervention than control communities and if the variance among community responses is larger among control communities than among intervention communities; size may also exceed nominal levels if there are more control than intervention communities and if the variance among community responses is larger among intervention communities. Otherwise, size is likely near nominal levels. To avoid such problems, we recommend use of the same numbers of control and intervention communities in unmatched designs. Pair‐matched designs usually have size near nominal levels, even under the weak null hypothesis. We have identified some extreme cases, unlikely to arise in practice, in which even the size of pair‐matched studies can exceed nominal levels. These simulations, however, tend to confirm the robustness of randomization tests for matched and unmatched community intervention trials, particularly if the latter designs have equal numbers of intervention and control communities. We also describe adaptations of randomization tests to allow for covariate adjustment, missing data, and application to cross‐sectional surveys. We show that covariate adjustment can increase power, but such power gains diminish as the random component of variation among communities increases, which corresponds to increasing intraclass correlation of responses within communities. We briefly relate our results to model‐based methods of inference for community intervention trials that include hierarchical models such as an analysis of variance model with random community effects and fixed intervention effects. Although we have tailored this paper to the design of community intervention trials, many of the ideas apply to other experiments in which one allocates groups or clusters of subjects at random to intervention or control treatments.

Number of times cited according to CrossRef: 120

  • RE-AIM Evaluation Plan for Washington State Innovation Models Project, Quality Management in Health Care, 10.1097/QMH.0000000000000246, 29, 2, (81-94), (2020).
  • Essential Ingredients and Innovations in the Design and Analysis of Group-Randomized Trials, Annual Review of Public Health, 10.1146/annurev-publhealth-040119-094027, 41, 1, (1-19), (2020).
  • Power analysis for cluster randomized trials with multiple binary co‐primary endpoints, Biometrics, 10.1111/biom.13212, 0, 0, (2020).
  • Randomization-based confidence intervals for cluster randomized trials, Biostatistics, 10.1093/biostatistics/kxaa007, (2020).
  • Mixed-effects models for the design and analysis of stepped wedge cluster randomized trials: An overview, Statistical Methods in Medical Research, 10.1177/0962280220932962, (096228022093296), (2020).
  • Randomization Tests for Weak Null Hypotheses in Randomized Experiments, Journal of the American Statistical Association, 10.1080/01621459.2020.1750415, (1-16), (2020).
  • Novel methods for the analysis of stepped wedge cluster randomized trials, Statistics in Medicine, 10.1002/sim.8451, 39, 7, (815-844), (2019).
  • A community health worker-led multimedia intervention to increase cervical cancer screening uptake among South Asian women: study protocol for a cluster randomized wait-list controlled trial, Trials, 10.1186/s13063-019-3378-4, 20, 1, (2019).
  • Robust and Powerful Differential Composition Tests for Clustered Microbiome Data, Statistics in Biosciences, 10.1007/s12561-019-09251-5, (2019).
  • A Permutation Test on Complex Sample Data, Journal of Survey Statistics and Methodology, 10.1093/jssam/smz018, (2019).
  • Empirical Insights for Improving Sexual Assault Prevention: Evidence From Baseline Data for a Cluster-Randomized Trial of IMPower and Sources of Strength, Violence Against Women, 10.1177/1077801219886380, (107780121988638), (2019).
  • Optimal Weighted Wilcoxon–Mann–Whitney Test for Prioritized Outcomes, New Frontiers of Biostatistics and Bioinformatics, 10.1007/978-3-319-99389-8_1, (3-40), (2018).
  • Cvcrand and Cptest: Commands for Efficient Design and Analysis of Cluster Randomized Trials Using Constrained Randomization and Permutation Tests, The Stata Journal: Promoting communications on statistics and Stata, 10.1177/1536867X1801800204, 18, 2, (357-378), (2018).
  • Cluster-Randomized Test-Negative Design Trials: A Novel and Efficient Method to Assess the Efficacy of Community-Level Dengue Interventions, American Journal of Epidemiology, 10.1093/aje/kwy099, 187, 9, (2021-2028), (2018).
  • The World Cup, Nationalism, and International Trade, SSRN Electronic Journal, 10.2139/ssrn.3194308, (2018).
  • Design and analysis of group-randomized trials in cancer: A review of current practices, Preventive Medicine, 10.1016/j.ypmed.2018.03.010, 111, (241-247), (2018).
  • Peer mentor versus teacher delivery of a physical activity program on the effects of BMI and daily activity: protocol of a school-based group randomized controlled trial in Appalachia, BMC Public Health, 10.1186/s12889-018-5537-z, 18, 1, (2018).
  • Improving the delivery and organisation of mental health services: Beyond the conventional randomised controlled trial, British Journal of Psychiatry, 10.1192/bjp.180.1.13, 180, 1, (13-18), (2018).
  • Optimal Allocation of Interviews to Baseline and Endline Surveys in Place-Based Randomized Trials and Quasi-Experiments, Evaluation Review, 10.1177/0193841X18799128, (0193841X1879912), (2018).
  • A randomization-based perspective on analysis of variance: a test statistic robust to treatment effect heterogeneity, Biometrika, 10.1093/biomet/asx059, 105, 1, (45-56), (2017).
  • The Econometrics of Randomized Experiments a, Handbook of Field Experiments, 10.1016/bs.hefe.2016.10.003, (73-140), (2017).
  • Maximin optimal designs for cluster randomized trials, Biometrics, 10.1111/biom.12659, 73, 3, (916-926), (2017).
  • An evaluation of constrained randomization for the design and analysis of group‐randomized trials with binary outcomes, Statistics in Medicine, 10.1002/sim.7410, 36, 24, (3791-3806), (2017).
  • The use of permutation tests for the analysis of parallel and stepped‐wedge cluster‐randomized trials, Statistics in Medicine, 10.1002/sim.7329, 36, 18, (2831-2843), (2017).
  • LOCAL PERIARTICULAR ANALGESIA IN TOTAL KNEE ARTHROPLASTY, Acta Ortopédica Brasileira, 10.1590/1413-785220172502151116, 25, 2, (81-84), (2017).
  • The Design of Cluster Randomized Trials With Random Cross-Classifications, Journal of Educational and Behavioral Statistics, 10.3102/1076998617730303, (107699861773030), (2017).
  • An optimal Wilcoxon–Mann–Whitney test of mortality and a continuous outcome, Statistical Methods in Medical Research, 10.1177/0962280216680524, (096228021668052), (2016).
  • Robustness of ordinary least squares in randomized clinical trials, Statistics in Medicine, 10.1002/sim.6839, 35, 11, (1763-1773), (2015).
  • An evaluation of constrained randomization for the design and analysis of group‐randomized trials, Statistics in Medicine, 10.1002/sim.6813, 35, 10, (1565-1579), (2015).
  • Recommendations for choosing an analysis method that controls Type I error for unbalanced cluster sample designs with Gaussian outcomes, Statistics in Medicine, 10.1002/sim.6565, 34, 27, (3531-3545), (2015).
  • Theory-Driven Process Evaluation of the SHINE Trial Using a Program Impact Pathway Approach, Clinical Infectious Diseases, 10.1093/cid/civ716, 61, suppl 7, (S752-S758), (2015).
  • A population-based, multifaceted strategy to implement antenatal corticosteroid treatment versus standard care for the reduction of neonatal mortality due to preterm birth in low-income and middle-income countries: the ACT cluster-randomised trial, The Lancet, 10.1016/S0140-6736(14)61651-2, 385, 9968, (629-639), (2015).
  • Methods for sample size determination in cluster randomized trials, International Journal of Epidemiology, 10.1093/ije/dyv113, 44, 3, (1051-1067), (2015).
  • Cluster Randomized Trials, Handbook of Epidemiology, 10.1007/978-0-387-09834-0, (389-417), (2014).
  • Permutation Tests in Clinical Trials, Methods and Applications of Statistics in Clinical Trials, 10.1002/9781118596333, (527-535), (2014).
  • Effect of Decision Support on Missed Opportunities for Human Papillomavirus Vaccination, American Journal of Preventive Medicine, 10.1016/j.amepre.2014.08.010, 47, 6, (734-744), (2014).
  • Epidemiology, The Work of Raymond J. Carroll, 10.1007/978-3-319-05801-6, (195-292), (2014).
  • Permutation Tests in Clinical Trials, Wiley StatsRef: Statistics Reference Online, 10.1002/9781118445112, (2014).
  • Group‐Randomization Designs, Wiley StatsRef: Statistics Reference Online, 10.1002/9781118445112, (2014).
  • Assessing outcomes of a stigma-reduction intervention with venue-based analysis, Social Psychiatry and Psychiatric Epidemiology, 10.1007/s00127-013-0808-6, 49, 6, (991-999), (2013).
  • On small‐sample inference in group randomized trials with binary outcomes and cluster‐level covariates, Biometrical Journal, 10.1002/bimj.201200237, 55, 5, (789-806), (2013).
  • The Utility of a Composite Biological Endpoint in HIV/STI Prevention Trials, AIDS and Behavior, 10.1007/s10461-013-0501-5, 17, 9, (2893-2901), (2013).
  • Prevalence of Trypanosoma cruzi Infection among People Aged 15 to 89 Years Inhabiting the Department of Casanare (Colombia), PLoS Neglected Tropical Diseases, 10.1371/journal.pntd.0002113, 7, 3, (e2113), (2013).
  • Augmented generalized estimating equations for improving efficiency and validity of estimation in cluster randomized trials by leveraging cluster‐level and individual‐level covariates, Statistics in Medicine, 10.1002/sim.4471, 31, 10, (915-930), (2012).
  • Bibliography, A–Z of Error-Free Research, 10.1201/b12362, (233-238), (2012).
  • Bibliography, Common Errors in Statistics (And How to Avoid Them), 10.1002/9781118360125, (291-318), (2012).
  • A Powerful and Robust Test Statistic for Randomization Inference in Group‐Randomized Trials with Matched Pairs of Groups, Biometrics, 10.1111/j.1541-0420.2011.01622.x, 68, 1, (75-84), (2011).
  • Robust extraction of covariate information to improve estimation efficiency in randomized trials, Statistics in Medicine, 10.1002/sim.4301, 30, 19, (2389-2408), (2011).
  • Cutoff designs for community‐based intervention studies, Statistics in Medicine, 10.1002/sim.4237, 30, 15, (1865-1882), (2011).
  • Epidemiological methods in diarrhoea studies—an update, International Journal of Epidemiology, 10.1093/ije/dyr152, 40, 6, (1678-1692), (2011).
  • Intraclass Correlation Associated with Therapists: Estimates and Applications in Planning Psychotherapy Research, Cognitive Behaviour Therapy, 10.1080/16506073.2010.520731, 40, 1, (15-33), (2011).
  • Design of a randomized clinical trial to improve rates of amblyopia detection in preschool aged children in primary care settings, Contemporary Clinical Trials, 10.1016/j.cct.2010.10.009, 32, 2, (204-214), (2011).
  • Statistical Methods and Challenges in Epidemiology and Biomedical Research, Essential Statistical Methods for Medical Statistics, 10.1016/B978-0-444-53737-9.50004-9, (1-26), (2011).
  • Standardized discharge orders after stroke: Results of the quality improvement in stroke prevention (QUISP) cluster randomized trial, Annals of Neurology, 10.1002/ana.22019, 67, 5, (579-589), (2010).
  • Exact Inference for Complex Clustered Data Using Within-Cluster Resampling, Journal of Biopharmaceutical Statistics, 10.1080/10543401003618884, 20, 4, (850-869), (2010).
  • Cluster Trials, Encyclopedia of Biopharmaceutical Statistics, 10.3109/9781439822463, (304-311), (2010).
  • Design and implementation of a dental caries prevention trial in remote Canadian Aboriginal communities, Trials, 10.1186/1745-6215-11-54, 11, 1, (2010).
  • The Role of ANCOVA in Analyzing Experimental Data, Psychiatric Annals, 10.3928/00485713-20090625-01, 39, 7, (753-760), (2009).
  • A SAS macro for a clustered permutation test, Computer Methods and Programs in Biomedicine, 10.1016/j.cmpb.2009.02.005, 95, 1, (89-94), (2009).
  • An application of a modified constrained randomization process to a practice-based cluster randomized trial to improve colorectal cancer screening, Contemporary Clinical Trials, 10.1016/j.cct.2008.10.002, 30, 2, (129-132), (2009).
  • HEALTHY study rationale, design and methods: moderating risk of type 2 diabetes in multi-ethnic middle school students, International Journal of Obesity, 10.1038/ijo.2009.112, 33, S4, (S4-S20), (2009).
  • The Effects of High Stakes High School Achievement Awards: Evidence from a Randomized Trial, American Economic Review, 10.1257/aer.99.4.1384, 99, 4, (1384-1414), (2009).
  • A simple approach to test for interaction between intervention and an individual‐level variable in community randomized trials, Tropical Medicine & International Health, 10.1111/j.1365-3156.2007.01997.x, 13, 2, (247-255), (2008).
  • A Bayesian multilevel model for estimating the diet/disease relationship in a multicenter study with exposures measured with error: The EPIC study, Statistics in Medicine, 10.1002/sim.3444, 27, 29, (6037-6054), (2008).
  • Bibliography, Common Errors in Statistics (and How to Avoid Them), 10.1002/9780470473924, (237-257), (2008).
  • Design and Analysis of Group-Randomized Trials in Cancer: A Review of Current Practices, JNCI Journal of the National Cancer Institute, 10.1093/jnci/djn066, 100, 7, (483-491), (2008).
  • Cluster without fluster: The effect of correlated outcomes on inference in randomized clinical trials, Statistics in Medicine, 10.1002/sim.2977, 27, 6, (795-809), (2007).
  • Limitations of the Randomized Controlled Trial in Evaluating Population-Based Health Interventions, American Journal of Preventive Medicine, 10.1016/j.amepre.2007.04.007, 33, 2, (155-161), (2007).
  • 1 Statistical Methods and Challenges in Epidemiology and Biomedical Research, Epidemiology and Medical Statistics, 10.1016/S0169-7161(07)27001-4, (1-27), (2007).
  • Addressing challenges in adolescent smoking cessation: Design and baseline characteristics of the HS Group-Randomized trial, Preventive Medicine, 10.1016/j.ypmed.2007.05.018, 45, 2-3, (215-225), (2007).
  • Permutation Tests in Clinical Trials, Wiley Encyclopedia of Clinical Trials, 10.1002/9780471462422, (2007).
  • The Community Intervention Trial for Smoking Cessation (COMMIT), Wiley Encyclopedia of Clinical Trials, 10.1002/9780471462422, (2007).
  • Design and analysis of stepped wedge cluster randomized trials, Contemporary Clinical Trials, 10.1016/j.cct.2006.05.007, 28, 2, (182-191), (2007).
  • Methods for the statistical analysis of binary data in split‐mouth designs with baseline measurements, Statistics in Medicine, 10.1002/sim.2782, 26, 18, (3476-3486), (2006).
  • Developments in cluster randomized trials and Statistics in Medicine, Statistics in Medicine, 10.1002/sim.2731, 26, 1, (2-19), (2006).
  • A Mixed Model‐Based Variance Estimator for Marginal Model Analyses of Cluster Randomized Trials, Biometrical Journal, 10.1002/bimj.200510280, 49, 3, (394-405), (2006).
  • Analysis strategies for a community trial to reduce adolescent ATOD use: A comparison of random coefficient and ANOVA/ANCOVA models, Contemporary Clinical Trials, 10.1016/j.cct.2005.09.008, 27, 2, (188-206), (2006).
  • A SAS macro for constrained randomization of group-randomized designs, Computer Methods and Programs in Biomedicine, 10.1016/j.cmpb.2006.04.011, 83, 3, (205-210), (2006).
  • Dissemination of the Canadian clinical practice guidelines for nutrition support: Results of a cluster randomized controlled trial, Critical Care Medicine, 10.1097/01.CCM.0000234044.91893.9C, 34, 9, (2362-2369), (2006).
  • Statistical Considerations for NonInferiority/Equivalence Trials in Vaccine Development, Journal of Biopharmaceutical Statistics, 10.1080/10543400600719251, 16, 4, (429-441), (2006).
  • Longitudinal and repeated cross‐sectional cluster‐randomization designs using mixed effects regression for binary outcomes: bias and coverage of frequentist and Bayesian methods, Statistics in Medicine, 10.1002/sim.2428, 25, 16, (2720-2736), (2005).
  • Power and money in cluster randomized trials: when is it worth measuring a covariate?, Statistics in Medicine, 10.1002/sim.2297, 25, 15, (2607-2617), (2005).
  • A comparison of permutation and mixed‐model regression methods for the analysis of simulated data in the context of a group‐randomized trial, Statistics in Medicine, 10.1002/sim.2233, 25, 3, (375-388), (2005).
  • Randomization of Clusters Versus Randomization of Persons Within Clusters, The American Statistician, 10.1198/000313005X20727, 59, 1, (72-78), (2005).
  • Randomization of Clusters Versus Randomization of Persons Within Clusters, The American Statistician, 10.1198/000313005X43542, 59, 2, (173-179), (2005).
  • Randomization Tests, Encyclopedia of Biostatistics, 10.1002/0470011815, (2005).
  • Group‐Randomization Designs, Encyclopedia of Biostatistics, 10.1002/0470011815, (2005).
  • Cluster Randomization, Encyclopedia of Biostatistics, 10.1002/0470011815, (2005).
  • Small Sample Inference for Clustered Data, Proceedings of the Second Seattle Symposium in Biostatistics, 10.1007/978-1-4419-9076-1_5, (71-87), (2004).
  • Mounting a community-randomized trial: sample size, matching, selection, and randomization issues in PRISM, Controlled Clinical Trials, 10.1016/j.cct.2003.12.002, 25, 3, (235-250), (2004).
  • Methods for the Statistical Analysis of Binary Data in Split‐Cluster Designs, Biometrics, 10.1111/j.0006-341X.2004.00247.x, 60, 4, (919-925), (2004).
  • Methods for modelling change in cluster randomization trials, Statistics in Medicine, 10.1002/sim.1858, 23, 15, (2341-2357), (2004).
  • Some Thoughts on Causation as It Relates to Demography and Population Studies, Population and Development Review, 10.1111/j.1728-4457.2003.00459.x, 29, 3, (459-469), (2004).
  • Valid Inference in Random Effects Meta‐Analysis, Biometrics, 10.1111/j.0006-341X.1999.00732.x, 55, 3, (732-737), (2004).
  • Choice of test for comparing two groups, with particular application to skewed outcomes, Statistics in Medicine, 10.1002/sim.1420, 22, 8, (1205-1215), (2003).
  • An integrated population‐averaged approach to the design, analysis and sample size determination of cluster‐unit trials, Statistics in Medicine, 10.1002/sim.1379, 22, 8, (1235-1254), (2003).
  • Pesticide Take-Home Pathway among Children of Agricultural Workers: Study Design, Methods, and Baseline Findings, Journal of Occupational and Environmental Medicine, 10.1097/00043764-200301000-00012, 45, 1, (42-53), (2003).
  • Identifying settings when permutation tests have nominal size with paired, binary-outcome, group randomized trials, Journal of Nonparametric Statistics, 10.1080/10485250310001624765, 15, 6, (653-663), (2003).
  • The effects of alternative study designs on the power of community randomized trials: evidence from three studies of human immunodeficiency virus prevention in East Africa, International Journal of Epidemiology, 10.1093/ije/dyg150, 32, 5, (755-762), (2003).
  • Outcome measures and needs assessment tools for schizophrenia and related disorders, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD003081, (2003).
  • See more

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.